Search Results 1-10 of 17295 for Pompe Disease
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Description. Alglucosidase alfa injection is an enzyme used to treat Pompe disease (glycogen storage disease type II), including infantile-onset Pompe ...
People with Pompe disease are not able to make enough of this enzyme. This medicine is to be given only by or under the direct supervision of your doctor ...
People with Pompe disease are not able to make enough of this enzyme. This medicine is to be given only by or under the direct supervision of your doctor. This ...
Miglustat is used in combination with cipaglucosidase alfa-atga injection (Pombiliti™) to treat late-onset of Pompe disease in patients who are not improving on ...
... Pompe Disease. Genet Med. 2025 Oct 10; 101604 [Epub ahead of print] View PubMed; Hall PL, White AL, Peck D, Pino G, Studinski A, Gavrilov D, Oglesbee D ...
... Pompe disease. Genet Med. 2026 Jan; 28 (1):101604 Epub 2025 Oct 10. View PubMed; Ding Q, Salsbery KT, Vidal-Folch N, Oglesbee D, Hasadsri L. Prenatal testing ...
2025 - present. MemberAmerican College of Medical Genetics and Genomics - Therapeutics Committee · 2024 - present. MemberMinnesota Pompe Disease Consortium · 2024 ...
Search for a disease or condition . Type 3 or more letters to display ... MemberMinnesota Pompe Disease Consortium. 2019 - present. MemberData Safety ...
... Pompe Disease and Other Lysosomal Storage Disorders (NBS07). 2013 - present. MemberDLMP Finance Committee, Department of Laboratory Medicine and Pathology.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.